# Feasibility of Molecular Biology in Pancreatic Cyst Tumors

> **NCT03305146** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hospital St. Joseph, Marseille, France** · enrollment: 93 (actual)

## Conditions studied

- Pancreatic Cyst
- Pancreas Cyst
- Serous Cystadenoma
- Mucinous Cystadenoma
- IPMN

## Interventions

- **GENETIC:** Molecular biology analysis of pancreatic intra-cyst fluid

## Key facts

- **NCT ID:** NCT03305146
- **Lead sponsor:** Hospital St. Joseph, Marseille, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01
- **Primary completion:** 2017-12
- **Final completion:** 2027-01
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03305146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03305146, "Feasibility of Molecular Biology in Pancreatic Cyst Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03305146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*